[1]
A. Zafar, W. Sattar, M. M. Ud Din, S. Yaqub, Z. A. K. Niazi, and M. A. Khokhar, “Response of Bortezomib Versus Non-Bortezomib Based Regimen in Newly Diagnosed Patients of Multiple Myeloma”, Esculapio - JSIMS, vol. 17, no. 4, pp. 322–325, Jul. 2023.